Teaching harm reduction in vulnerable environments (THRIVE): a peer-led intervention bridging acute care settings and the discharge to the community
教导在脆弱环境中减少伤害(THRIVE):由同伴主导的干预措施,将急症护理环境与出院到社区联系起来
基本信息
- 批准号:10589388
- 负责人:
- 金额:$ 4.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdoptionBehaviorBehavioralBlack PopulationsClinicalClinical TrialsCommunitiesCoupledDataDecision MakingDrug userEducationEducational process of instructingElectronic Health RecordElementsEnvironmentEvidence based practiceFentanylFundingGoalsHarm ReductionHealthHealth PersonnelHealth ProfessionalHealth systemHealthcare SystemsHeterogeneityHomeHospital DepartmentsHospitalsHybridsIncidenceIndividualInjectionsInterventionInterviewKnowledgeLeadMapsMeasuresMedicalMethodologyModelingMorbidity - disease rateMotivationNaloxoneOpioidOutcomeOverdoseOverdose reductionPatient RecruitmentsPatient Self-ReportPatientsPersonsPopulationProcessPublic HealthRaceRandomized Controlled TrialsResearchRiskSamplingSelf EfficacySeriesServicesSiteSkin TissueSoft Tissue InfectionsStructureSubstance Use DisorderSurveysTeaching MethodTestingText MessagingTheoretical Domains frameworkTrustUnited States National Institutes of Healthacute carebasebehavior changebehavioral health interventionclinical carecommunity settingdesignefficacy evaluationevidence baseexperiencehealth care settingshealth equityhuman centered designimplementation barriersimplementation facilitatorsimplementation frameworkimprovedimproved outcomeinternalized stigmamortalitynovelopioid use disorderoverdose deathpatient-level barrierspeerprimary outcomeprovider-level barriersracial disparityreduced substance useservice gapskillssocial stigmasubstance usesystem-level barrierstest striptherapy designtreatment as usualtreatment effect
项目摘要
ABSTRACT
People who use drugs (PWUD) with acute medical problems have high rates of subsequent mortality and
morbidity related to substance use, with notable racial disparities. While harm reduction services to reduce
overdose and injection-related complications have historically functioned outside of health care settings,
integrating harm reduction into acute care clinical settings could improve these outcomes. There is a critical
gap in how best to implement harm reduction services in the health system that will lead to effective behavioral
change and address equity gaps. Our study proposes to develop an acceptable, feasible, and effective peer-led
bundle of harm reduction services. Our overall objectives are to tailor the THRIVE (Teaching Harm Reduction
In Vulnerable Environments) intervention and determine its efficacy in changing behaviors and reducing
health risks among PWUD. The THRIVE intervention was conceptualized by our team along with people with
lived experience and informed by the COM-B model for Behavior Change and the Theoretical Domains
Framework. THRIVE bundles evidence-based harm reduction strategies (e.g. safer injection education, take
home naloxone, and fentanyl test strips). It includes a face-to-face session boosted by weekly text messages and
electronic content. Content is delivered over 12 weeks. Our research team has the extensive expertise in
community-partnered research, qualitative methodology, behavioral health intervention design, and clinical
trial management needed to successfully complete the proposed aims. We will use a human-centered design
approach to tailor the THRIVE model and address the patient, provider, and systems-level barriers to
implementation in hospital and emergency-department settings. This includes a “Design Sprint” in which
PWUD will map the problem (guided by qualitative interviews with patients and healthcare providers), sketch
implementation elements, choose the key aspects to develop, and build model components. These
implementation methods for the THRIVE model will then be user-tested with 20 patients over an 8-week
period. We will then examine the efficacy of the THRIVE intervention in reducing the cumulative incidence of
self-reported non-fatal overdose or skin and soft tissue infection between baseline and 6-months among
PWUD in a hybrid type 1 randomized controlled trial. We will conduct a randomized controlled trial recruiting
patients (n=390) admitted to the hospital or Emergency Department with opioid use disorder in one of three
hospitals. We will also analyze implementation barriers and facilitators of the THRIVE model using the health
equity implementation framework to identify any needed implementation supports for widescale
implementation.
摘要
使用药物(PWUD)并有急性医疗问题的人随后的死亡率和
与药物使用有关的发病率,有明显的种族差异。在减少危害服务的同时减少
服药过量和与注射相关的并发症历来在医疗保健环境之外发挥作用,
将减少危害纳入急性护理临床环境可以改善这些结果。有一个关键的问题
在如何最好地在卫生系统中实施减少危害服务方面的差距将导致有效的行为
改变和解决股权差距。我们的研究建议发展一种可接受的、可行的、有效的同行领导
减少危害服务捆绑包。我们的总体目标是量身定做Thrive(减少伤害教学
在脆弱环境中)干预并确定其在改变行为和减少
残障人士的健康风险。Thrive干预是由我们的团队与
生活体验和受COM-B模型影响的行为改变及其理论领域
框架。Thrive捆绑以证据为基础的减少伤害战略(例如,更安全的注射教育,采取
国产纳洛酮和芬太尼试纸)。它包括面对面的会议,由每周的短信和
电子内容。内容交付时间为12周。我们的研究团队拥有丰富的专业知识
社区合作研究、定性方法、行为健康干预设计和临床
试验管理需要成功地完成拟议的目标。我们将采用以人为中心的设计
定制Thrive模型并解决患者、提供商和系统级障碍的方法
在医院和急诊科环境中实施。其中包括《设计冲刺》,在这个节目中
PWUD将绘制问题图(通过对患者和医疗保健提供者的定性访谈进行指导)、草图
实现元素,选择要开发的关键方面,并构建模型组件。这些
Thrive模型的实施方法将在8周内与20名患者进行用户测试
句号。然后,我们将研究Thrive干预措施在降低心绞痛累积发病率方面的有效性
在基线和6个月之间自我报告的非致命性服药过量或皮肤和软组织感染
PWUD是一项混合型1型随机对照试验。我们将进行随机对照试验招募
住院或急诊科阿片类药物使用障碍患者(n=390)
医院。我们还将使用Health分析Thrive模式的实施障碍和推动者
公平实施框架,以确定任何需要的大规模实施支持
实施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacqueline Deanna Wilson其他文献
Jacqueline Deanna Wilson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacqueline Deanna Wilson', 18)}}的其他基金
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10834850 - 财政年份:2023
- 资助金额:
$ 4.96万 - 项目类别:
Teaching harm reduction in vulnerable environments (THRIVE): a peer-led intervention bridging acute care settings and the discharge to the community
教导在脆弱环境中减少伤害(THRIVE):由同伴主导的干预措施,将急症护理环境与出院到社区联系起来
- 批准号:
10834851 - 财政年份:2022
- 资助金额:
$ 4.96万 - 项目类别:
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10053965 - 财政年份:2020
- 资助金额:
$ 4.96万 - 项目类别:
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10424528 - 财政年份:2020
- 资助金额:
$ 4.96万 - 项目类别:
Treatment of Opioid Use Disorder in Young Adults Hospitalized with Infectious Complications of Injection Opioid Use
因注射阿片类药物使用引起感染性并发症而住院的年轻人阿片类药物使用障碍的治疗
- 批准号:
10197083 - 财政年份:2020
- 资助金额:
$ 4.96万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 4.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 4.96万 - 项目类别:
Operating Grants














{{item.name}}会员




